Pfizer Inc (PFE)
28.16
+0.35
(+1.26%)
USD |
NYSE |
May 06, 16:00
28.23
+0.07
(+0.25%)
Pre-Market: 09:10
Pfizer Total Long Term Debt (Quarterly): 0.00 for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 70.84B |
September 30, 2023 | 63.60B |
June 30, 2023 | 65.34B |
March 31, 2023 | 34.93B |
December 31, 2022 | 34.86B |
September 30, 2022 | 35.68B |
June 30, 2022 | 39.13B |
March 31, 2022 | 35.05B |
December 31, 2021 | 37.00B |
September 30, 2021 | 38.41B |
June 30, 2021 | 37.74B |
March 31, 2021 | 38.19B |
December 31, 2020 | 38.27B |
September 30, 2020 | 61.53B |
June 30, 2020 | 63.61B |
March 31, 2020 | 52.28B |
December 31, 2019 | 50.84B |
September 30, 2019 | 52.65B |
June 30, 2019 | 46.67B |
March 31, 2019 | 45.14B |
December 31, 2018 | 41.74B |
September 30, 2018 | 48.43B |
June 30, 2018 | 40.52B |
March 31, 2018 | 40.83B |
Date | Value |
---|---|
December 31, 2017 | 42.61B |
September 30, 2017 | 43.95B |
June 30, 2017 | 43.70B |
March 31, 2017 | 44.01B |
December 31, 2016 | 41.06B |
September 30, 2016 | 44.07B |
June 30, 2016 | 44.18B |
March 31, 2016 | 39.37B |
December 31, 2015 | 38.90B |
September 30, 2015 | 38.90B |
June 30, 2015 | 35.12B |
March 31, 2015 | 35.92B |
December 31, 2014 | 36.68B |
September 30, 2014 | 37.06B |
June 30, 2014 | 37.83B |
March 31, 2014 | 36.97B |
December 31, 2013 | 36.49B |
September 30, 2013 | 36.55B |
June 30, 2013 | 36.75B |
March 31, 2013 | 40.38B |
December 31, 2012 | 37.46B |
September 30, 2012 | 38.86B |
June 30, 2012 | 38.57B |
March 31, 2012 | 39.07B |
December 31, 2011 | 38.94B |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2024
70.84B
Maximum
Dec 2023
44.83B
Average
38.77B
Median
Total Long Term Debt (Quarterly) Benchmarks
Amgen Inc | 64.02B |
Johnson & Johnson | 33.63B |
Eli Lilly and Co | 26.21B |
Viking Therapeutics Inc | -- |
Moderna Inc | 0.00 |